Israel to launch consortium focused on AI and gene editing
The Israel Innovation Authority (IIA) has approved the creation of a consortium aimed at integrating artificial intelligence and genome editing technologies. The consortium will focus on harnessing AI for developing advanced tools for genome editing, with increased efficiency and accuracy. Such tools are mainly intended to be used in the fields of medicine and agriculture. It will bring together private companies, universities, and research institutes in the country. As noted by IIA’s CEO Aharon Aharon, the overall goal behind the consortium is to ‘enable Israeli industry to be at the forefront of genome editing worldwide, while recruiting leading scientists and deploying innovative technologies developed in Israel’.
About author
DW Team
The GIP Digital Watch Observatory team, consisting of over 30 digital policy experts from around the world, excels in the fields of research and analysis on digital policy issues. The team is backed by the creative prowess of Creative Lab Diplo and the technical expertise of the Diplo tech team.
